FDA Calendar


Company Name Talon Therapeutics, Inc.
Drug Name Marqibo (NDA)
Event Name FDA decision on Marqibo in the proposed treatment of adult Philadelphia chromosome-negative acute lymphoblastic leukemia
Event Date 05/13/2012
Outcome FDA postpones decision on Marqibo by 3 months to August 12
Drug Status
Rival Drugs
Market Potential
Other Approvals
News
Inching Towards One Dollar Mark...
Return to FDA Calendar